WASHINGTON (Reuters) - Senators trying to promote human stem cell research rebuked a team of corporate scientists on Wednesday, saying their claims to have produced human embryonic stem cells without harming the embryo had misrepresented their work and hurt the cause.
Last month, the team at Advanced Cell Technology in Massachusetts said they had taken single cells from days-old embryos and used them to produce batches, or lines, of stem cells.
